N-type calcium channel α1B Inhibitors

Chemical inhibitors of N-type calcium channel α1B include a variety of compounds that act by different mechanisms to inhibit the flow of calcium ions through this channel. ω-Conotoxin GVIA and ω-Conotoxin MVIIA, peptide toxins from marine snails, directly bind to N-type calcium channel α1B and occlude the channel pore, blocking the influx of calcium ions. Similarly, ω-Agatoxin IVA, a peptide toxin from spider venom, adheres to the extracellular surface of the channel, preventing calcium entry. These toxins are highly selective for N-type calcium channels and effectively inhibit the flow of calcium ions by physically obstructing the channel.

Other chemical inhibitors, such as the dihydropyridines Nifedipine, Amlodipine, and Nicardipine, along with the phenylalkylamine Verapamil and the benzothiazepine Diltiazem, are traditionally associated with blocking L-type calcium channels. However, at higher concentrations, these chemicals can also inhibit N-type calcium channel α1B, reducing the conductance of calcium through these channels. The inhibition mechanism involves binding to the channel and altering its conformation, which decreases its ability to allow calcium ions to pass through. Furthermore, Gabapentin and Pregabalin, although primarily targeting the α2δ subunit of calcium channels, indirectly inhibit N-type calcium channel α1B. Their binding alters channel trafficking and kinetics, which results in a downstream reduction of calcium currents. Lastly, Ethosuximide and Zonisamide, while mainly targeting T-type calcium channels for their primary use, have been shown to inhibit N-type calcium channel α1B at higher concentrations. This inhibition contributes to their overall effect on calcium ion conductance within neurons. Each of these chemicals, by either direct blockade or indirect interaction with the channel or its auxiliary subunits, leads to a decrease in calcium ion conductance through N-type calcium channel α1B.